CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NURSES

ONCOLOGY Nurse Edition.
THE HARA/BLUM ARTICLE REVIEWED 

Social Challenges Can Be Significant

By KIM DAY, MSSA, LISW, OSW-C
Oncology Social Worker
University Hospitals Ireland Cancer Center
Cleveland, Ohio
| February 11, 2009
Financial Disclosure:
The author has no significant financial interest or other relationship with the manufacturers of any products or providers of any service mentioned in this article.

This Article reviews the following: Social Well-Being and Cancer Survivorship

 

In their informative article, Richard O’Hara and Diane Blum touch on several key challenges of cancer survivorship. Looking at cancer through the lens of social concerns and developmental issues, they have brought important psychosocial aspects of survivorship to the forefront of our attention, with a particular focus on the domain of social well-being within the parameters of interpersonal relationships, and financial, employment, insurance, and legal issues.

In terms of developmental factors, the authors do a good job of delineating the ways in which one’s life stage can affect the impact of cancer. The challenges faced by young adults are contrasted well with those of an older population whose life experiences and needs shape an experience of illness very different from that of younger survivors. Blum and Hara remind us that cancer is not just one disease and its impact does not lead to just one outcome or experience. Indeed the impact is multifactorial, widespread, and depends upon a host of factors including but not limited to personal life stage (eg, a survivor living with his or her parents vs one who is a parent to young children) and financial status.

While the authors cite survivors’ family relationships as integral to the social impact of cancer. I would like to have seen this aspect of cancer survivorship developed further beyond the sad but true fact that families have a strong need at the end of treatment to put the cancer experience behind them and return “normal” lives. We know that the tendency to see the illness as “over” and “in the past” exists, and we know that patients can suffer from feeling withdrawal of support from their families at a critical time.

That said, my curiosity is aroused as to the thoughts and feelings of family members as their loved ones grapple with how to make sense of their illness and find meaning in the cancer experience. Do families feel the disconnect in the same way that patients do? Do they feel left behind as patients explore new strategies for dealing with uncertainty? Are they harboring resentment about financial changes? How do patients and their families bridge this period with continued efforts to understand each other’s reality?

The financial implications of a cancer diagnosis are huge, and the myriad ways in which patient’s finances are impacted—from job loss, to job lock, to costs incurred with treatment copays and deductibles, as well as the high cost of insurance premiums and COBRA—are well described by the authors. They point out the travesty that more than half of American families filing for bankruptcy cite medical bills as the reason for their insolvency. Clearly, the financial hardship stemming from diagnosis and treatment of cancer cannot be overstated.

I agree with the authors’ basic premise that the impact of cancer on patients is devastating, but I question their suggestion that “stigma” is what holds people back in the workplace. According to Webster’s dictionary, the word “stigma” connotes disgrace or reproach; however, discrimination against cancer patients appears to be less about social disgrace and more about the financial bottom line for a company. Examples of cancer survivors in the public arena who have done well include Bob Dole, John Kerry, and John McCain; in the entertainment arena, Melissa Etheridge and Sheryl Crow; and in the world of sports, the first-class athlete, Lance Armstrong.

None of these people has been held back by “stigma.” Each has adequate wealth, suggesting to me that it is not the “stigma” of illness but rather the financial cost of illness that accounts for discrimination in the workplace. Words are powerful, so let us not use “stigma” to reinforce any negative view of cancer patients and let us instead label the phenomenon for what it is—discrimination based not on one’s disease but on a company’s operating budget.

Lastly, I offer kudos to the authors for the resources that they chose to include in their article: From a wealth of possible resources they skillfully selected the most essential in each category, providing a manageable yet complete list of referral sources from which to work. I also want to praise the authors for focusing attention on the social aspects of surviving cancer. As they point out, for some patients the psychosocial sequelae of this illness are as difficult to overcome as the physical ones.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

Implementing a Comprehensive Infection-Prevention Plan
May 6, 2013
ONS: Infection Risk, Prevention, and Management
April 29, 2013
ONS: Nurse-Physician PACT Yields Sharp Decrease in Codes
April 29, 2013
ONS: Safe Handling of Chemotherapy
April 29, 2013
ONS: Health IT as a Tool for Improved, Patient-Centric Care
April 26, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter



CancerNetwork on Facebook
 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Oncology Nursing
Evidence on Oncology Nursing
Guidelines on Oncology Nursing
Patient Education on Oncology Nursing
Clinical Trials on Oncology Nursing
Practical Articles on Oncology Nursing
Research and Reviews on Oncology Nursing
All "Oncology Nursing" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy